XRQ-22037-14344
3 vaccinations
4 coded responses
24 check-ins
4 free-text entries
0 call cases
- Sex
- —
- Age at first dose
- 0-4
- ZIP prefix
- 980 / WA
- Registered
- 2022-06-24
- Relationship
- Child or adolescent in my care
- Guardian
- 79V-24907-87680
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-22
Dose 1 — Pfizer-BioNTech
-
2022-06-24
Registered in v-safe
-
2022-06-24
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Pain · NoneUnder 3 check-in
-
2022-06-25
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
-
2022-06-27
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
- 2022-06-28
-
2022-06-29
Health check-in — day 7, dose 1, under 3Feeling: Poor · Fever · Irritability/crying, Loss of appetite, Diarrhea · Be unable to do your normal daily activitiesUnder 3 check-in
- 2022-07-06
-
2022-07-13
Dose 2 — Pfizer-BioNTech
- 2022-07-13
-
2022-07-14
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Sleepiness, Loss of appetiteUnder 3 check-in
- 2022-07-17
- 2022-07-18
- 2022-07-19
- 2022-07-20
- 2022-07-27
- 2022-08-03
- 2022-08-10
- 2022-08-17
-
2022-08-24
Survey response — day 42, dose 2, under 3MedDRA: Nasopharyngitis, Viral infection — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Cold virusMedDRA releases: 2024-11 · check-in free text available
-
2022-09-07
Dose 3 — Pfizer-BioNTech
- 2022-09-14
-
2022-09-21
Survey response — day 14, dose 3, under 3MedDRA: Respiratory tract congestion — Feeling: GoodFree text: CongestionMedDRA releases: 2024-11 · check-in free text available
-
2022-09-28
Survey response — day 21, dose 3, under 3MedDRA: Nasopharyngitis, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Cold congestionMedDRA releases: 2024-11 · check-in free text available
- 2022-10-12
- 2022-10-19
-
2022-12-07
Survey response — 3 months, dose 3, under 3MedDRA: Nasopharyngitis, Respiratory tract infection viral — Feeling: Fair · Be unable to work or attend schoolFree text: Respiratory virus/coldMedDRA releases: 2024-11 · check-in free text available
- 2023-03-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-22 | Pfizer-BioNTech | No |
| 2 | 2022-07-13 | Pfizer-BioNTech | No |
| 3 | 2022-09-07 | Pfizer-BioNTech | No |
Free text
Release 12 (Under 3) — day 42, dose 2, under 3
Symptoms: Cold virus
Release 12 (Under 3) — day 14, dose 3, under 3
Symptoms: Congestion
Release 12 (Under 3) — day 21, dose 3, under 3
Symptoms: Cold congestion
Release 12 (Under 3) — 3 months, dose 3, under 3
Symptoms: Respiratory virus/cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Respiratory tract infection viral | · | · | ✓ |
| SD | Viral infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release